The Pretoria High Court has dealt pharmaceutical giant Adcock Ingram a significant blow, ordering the company to cease selling and distributing its new painkiller, Lenbucod. This ruling effectively blocks Adcock Ingram’s Lenbucod from the market. The court found that the name infringed upon rival Aspen Pharmaceuticals’ existing trademark, Mybucod. This legal skirmish between the two JSE-listed heavyweights highlights the increasing…
Tag: Intellectual Property
-
Adcock Ingram’s Urizone Wins Trademark Battle
A South African court has ruled in favour of Adcock Ingram and Zambon SPA. It ordered Cipla Medpro to stop using the trademark Furizome for its urinary tract infection (UTI) medication. The court found Furizome to be confusingly similar to the established Urizone trademark, central to Adcock Ingram’s branding strategy. This led to a ruling based on trademark infringement and…